| Autor: |
Wainscott, David B., Krushinski, Joseph H., Audia, James E., Schaus, John M., Zgombick, John M., Lucaites, Virginia L., Nelson, David L. |
| Předmět: |
|
| Zdroj: |
Naunyn-Schmiedeberg's Archives of Pharmacology; Mar2005, Vol. 371 Issue 3, p169-177, 9p |
| Abstrakt: |
[3H]LY334370 was developed as a radioligand to study the characteristics of this compound’s interaction with the 5-HT1F receptor. Monovalent or divalent cations did not enhance the binding of [3H]LY334370 to the cloned human 5-HT1F receptor. In the presence of MgCl2, the time to reach equilibrium was approximately 2 h, while in its absence equilibrium was reached in less than 1 h. [3H]LY334370 had high affinity for the cloned human 5-HT1F receptor (Kd=0.446 nM) and the 5-HT1F receptor in rat brain (Kd=0.388 nM). The expression density of 5-HT1F receptors, as determined by binding to homogenates of cortical regions from rat, was low (Bmax=79.1 fmol/mg protein). There was a statistically significant correlation between the apparent pKi for inhibition of [3H]LY334370 binding and the pEC50 for stimulation of [35S]GTP?S binding to homogenates of cells expressing the cloned human 5-HT1F receptor. In addition, there was a statistically significant correlation between the apparent pKi for inhibition of [3H]LY334370 binding to the cloned human 5-HT1F receptor and the pID50 for inhibition of trigeminal nerve stimulated dural plasma protein extravasation in the guinea pig. The conclusion from these studies is that [3H]LY334370 is a high affinity radioligand which can be used for the study of the 5-HT1F receptor in rat brain or in cells transformed with the human 5-HT1F receptor. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink